Coverage
-
May 14, 2015
PharMerica Corp. will shell out $31.5 million, including more than $4 million to a whistleblower, to resolve alleged violations of the False Claims Act and the Controlled Substances Act tied to dispensing of painkillers without valid prescriptions, the U.S. Department of Justice said Thursday.
3 other articles on this case.
View all »